THE LONG-TERM RETENTION RATE OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS: DATA FROM THE NATIONAL ITALIAN REGISTRY GISEA

被引：1
|
作者：
Biggioggero, M. [1 ]
Gremese, E. [2 ]
Bugatti, S. [3 ]
Manfredi, A. [4 ]
Parisi, S. [5 ]
Bazzani, C. [6 ]
Carletto, A. [7 ]
Garaffoni, C. [8 ]
Semeraro, A. [9 ]
Corrado, A. [10 ]
Foti, R. [11 ]
Cauli, A. [12 ]
Spinelli, F. R. [13 ]
Iannone, F. [14 ]
Favalli, E. G. [1 ,15 ]
机构：
[1] ASST G Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy
[2] Univ Cattolica Sacro Cuore, Div Clin Immunol, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[3] Univ Pavia, Div Rheumatol, Fdn IRCCS Policlin San Matteo, Pavia, Italy
[4] Azienda Policlin Modena, Rheumatol Unit, Modena, Italy
[5] Azienda Osped Univ Citta Salute & Sci Torino, Dept Rheumatol, Turin, Italy
[6] Spedali Civili Brescia, Dept Rheumatol, Brescia, Italy
[7] Univ Verona, Rheumatol Unit, Verona, Italy
[8] Univ Ferrara, S Anna Hosp Ferrara, Dept Med Sci, Ferrara, Italy
[9] ASL Taranto PO Valle Itria, UO Reumatol, Martina Franca, Italy
[10] Univ Foggia, Rheumatol Unit, Foggia, Italy
[11] Policlin Univ Catania, Rheumatol Unit, Catania, Italy
[12] Univ Cagliari, Rheumatol Unit, Cagliari, Italy
[13] Sapienza Univ Roma, Azienda Policlin Umberto 1, Dipartimento Med Interna & Specialita Med, Rome, Italy
[14] Azienda Osped Univ Policlin Bari, Dipartimento Emergenza & Trapianto Organi, UOC Reumatol, Bari, Italy
[15] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Registries; Targeted synthetic drugs; Rheumatoid arthritis;
D O I：
10.1136/annrheumdis-2023-eular.4685
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0858
引用
收藏
页码：733 / 734
页数：2
相关论文
共 50 条
  • [21] Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    Kremer, Joel M.
    Griffith, Jenny
    Reed, George
    Salim, Bob
    Karki, Chitra
    Garg, Vishvas
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 375 - 389
  • [22] Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry
    Mok, Chi Chiu
    So, Ho
    Yim, Cheuk Wan
    To, Chi Hung
    Lao, Weng Nga
    Wong, Stella Pui Yan
    Ng, Hoi Yan
    Lee, Jolly Man Yee
    Lee, Patrick Man Leung
    Ying, Shirley King Yee
    Leung, Moon Ho
    Ho, Carmen Tze Kwan
    RHEUMATOLOGY, 2024, 63 (02) : 358 - 365
  • [23] SAFETY OF THE JAK INHIBITORS IN COMPARISON WITH THE TNF INHIBITORS IN RHEUMATOID ARTHRITIS: REAL WORLD DATA FROM THE HONG KONG BIOLOGICS REGISTRY
    Mok, C. C.
    So, H.
    Ho, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1331 - 1332
  • [24] EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY
    Sebastiani, M.
    Manfredi, A.
    Iannone, F.
    Gremese, E.
    Bortoluzzi, A.
    Favalli, E. G.
    Gorla, R.
    Salaffi, F.
    Fusaro, E.
    Foti, R.
    Cantarini, L.
    Caporali, R.
    Cauli, A.
    Alivernini, S.
    Cantatore, F. P.
    Carletto, A.
    Conti, F.
    D'Angelo, S.
    Epis, O.
    Cassone, G.
    Ramonda, R.
    Grosso, V.
    Sarzi-Puttini, P.
    Ferraccioli, G.
    Lapadula, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 957 - 957
  • [25] REMISSION AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: REVIEW OF REGISTRY DATA AND LONG-TERM COHORT STUDIES
    Peterson, S.
    Ganguly, R.
    Van Laer, J.
    Atanasov, P.
    Li, N.
    VALUE IN HEALTH, 2017, 20 (05) : A141 - A141
  • [26] Long-term data for adalimumab in severe rheumatoid arthritis
    Keystone, Edward
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (12) : 668 - 668
  • [27] Golimumab Therapy Retention Rates in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Data from the Italian Lorhen Registry
    Grosso, Vittorio
    Gorla, Roberto
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Pellerito, Raffaele
    Fusaro, Enrico
    Paolazzi, Giuseppe
    Rocchetta, Pier Andrea
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Caporali, Roberto
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1097 - S1098
  • [28] GOLIMUMAB THERAPY RETENTION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SERONEGATIVE SPONDYLOARTHRITIS: DATA FROM THE ITALIAN LORHEN REGISTRY
    Grosso, V.
    Gorla, R.
    Sarzi-Puttini, P.
    Atzeni, F.
    Pellerito, R.
    Fusaro, E.
    Paolazzi, G.
    Rocchetta, P. A.
    Favalli, E. G.
    Marchesoni, A.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 280 - 280
  • [29] Registry of Japanese rheumatoid arthritis patients on biologics for long-term safety
    Harigai, M
    Koike, R
    Ogawa, J
    Takeuchi, T
    Eguchi, K
    Miyasaka, N
    DRUG SAFETY, 2005, 28 (10) : 948 - 949
  • [30] Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting
    Serrano-Benavente, Belen
    Valor, Larissa
    del Rio Blasco, Tamara
    Janta, Iustina
    Gonzalez Benitez, Roberto
    Nieto-Gonzalez, Juan Carlos
    Martinez-Barrio, Julia
    Ovalles Bonilla, Juan Gabriel
    Ariza, Alfonso
    Lopez-Longo, Francisco Javier
    Alvaro-Gracia, Jose Maria
    Monteagudo, Indalecio
    Gonzalez-Fernandez, Carlos Manuel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E150 - E155
12345